text.skipToContent text.skipToNavigation
You searched for "293 Media / Transfection Support Media"
Too many choices? Use the filter option on the left to narrow your product listing.
1-10 of 980 results
1-10 of 1053 results
  • End-to-end process scalability of HEK 293 media for high titer AAV production
    Learn how our TheraPEAK® 293-GT Media Platform supports end-to-end acceleration of AAV development programs from small scale workflows through to manufacturing.
  • A robust system for high-titer, platform-agnostic AAV production in HEK293 cell lines
    Learn how the TheraPEAK® 293‑GT Media System supports success in AAV development through robust cell expansion, higher titers, and favorable full capsid ratios.
  • TheraPEAK 293-GT® Media
    Improve viral titers in your AAV program with our flexible media system
  • Primary Cells and Media Reference Guide
    A comprehensive collection of Lonza primary cell and media products supporting many research areas.
  • Lonza's Bulletkit® for Primary Cell Growth
    Primary Cells are Different from Cell Lines. Why use the Same Classical Media? Learn how Lonza primary cells and media can support your cell research
  • Instructions - Insect-XPRESS™ Media System
    Insect-XPRESS™ Medium protein free medium supports the growth of invertebrate cell lines derived from the fall army worm, Spodoptera frugiperda (Sf9 cells)
  • TheraPEAK 293-GT® Media System – Instructions for Use
    Read this protocol for detailed instructions for use
  • WinKQCL® Software Support Options
    Support options for WinKQCL® Software
  • Using Serum-free Media to Streamline CAR T-Cell Manufacturing Workflows
    Learn from this peer reviewed article, published in Cell and Gene Therapy Insights, how serum-free media can support large-scale, regulatory compliant expansion of CAR T-Cells.
  • A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell Expansion
    This poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.